453 related articles for article (PubMed ID: 10025826)
1. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
[TBL] [Abstract][Full Text] [Related]
2. [Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy].
Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Iwasaki T; Suzuki T; Nagai R
J Cardiol; 2000 Jul; 36(1):29-35. PubMed ID: 10929263
[TBL] [Abstract][Full Text] [Related]
3. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart.
Merlet P; Pouillart F; Dubois-Randé JL; Delahaye N; Fumey R; Castaigne A; Syrota A
J Nucl Med; 1999 Feb; 40(2):224-31. PubMed ID: 10025827
[TBL] [Abstract][Full Text] [Related]
4. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
[TBL] [Abstract][Full Text] [Related]
5. Dobutamine gated blood pool scintigraphy predicts the improvement of cardiac sympathetic nerve activity, cardiac function, and symptoms after treatment in patients with dilated cardiomyopathy.
Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Suzuki T; Kurabayashi M
Chest; 2002 Aug; 122(2):542-8. PubMed ID: 12171829
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.
Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A
Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933
[TBL] [Abstract][Full Text] [Related]
7. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
Agostini D; Belin A; Amar MH; Darlas Y; Hamon M; Grollier G; Potier JC; Bouvard G
J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
J Nucl Med; 2003 Oct; 44(10):1604-11. PubMed ID: 14530474
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
[TBL] [Abstract][Full Text] [Related]
10. Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2003 Jun; 44(6):884-90. PubMed ID: 12791814
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2002 Oct; 43(10):1279-85. PubMed ID: 12368364
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.
Merlet P; Benvenuti C; Moyse D; Pouillart F; Dubois-Randé JL; Duval AM; Loisance D; Castaigne A; Syrota A
J Nucl Med; 1999 Jun; 40(6):917-23. PubMed ID: 10452306
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].
Li S; Ikeda J; Takita T; Sekiguchi Y; Demachi J; Chikama H; Goto A; Shirato K
J Cardiol; 1998 Nov; 32(5):323-9. PubMed ID: 9864689
[TBL] [Abstract][Full Text] [Related]
15. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
Takeishi Y; Atsumi H; Fujiwara S; Takahashi K; Tomoike H
J Nucl Med; 1997 Jul; 38(7):1085-9. PubMed ID: 9225795
[TBL] [Abstract][Full Text] [Related]
16. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Am Coll Cardiol; 2003 Feb; 41(4):574-81. PubMed ID: 12598068
[TBL] [Abstract][Full Text] [Related]
17. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy.
Fukuoka S; Hayashida K; Hirose Y; Shimotsu Y; Ishida Y; Kakuchi H; Eto T
Eur J Nucl Med; 1997 May; 24(5):523-9. PubMed ID: 9142733
[TBL] [Abstract][Full Text] [Related]
18. Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy.
Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Suzuki J; Matsunaka T; Nakata S; Shigematsu Y
Circ J; 2002 Dec; 66(12):1139-43. PubMed ID: 12499621
[TBL] [Abstract][Full Text] [Related]
19. Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by [123I]-MIBG: relationship with left ventricular perfusion and function.
Pace L; Betocchi S; Losi MA; Della Morte AM; Ciampi Q; Nugnez R; Chiariello M; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):20-5. PubMed ID: 15195000
[TBL] [Abstract][Full Text] [Related]
20. [The significance of 201Tl/123I MIBG (metaiodobenzylguanidine) mismatched myocardial regions for predicting ventricular tachycardia in patients with idiopathic dilated cardiomyopathy].
Maeno M; Ishida Y; Shimonagata T; Hayashida K; Toyama T; Hirose Y; Nagata M; Miyatake K; Uehara T; Nishimura T
Kaku Igaku; 1993 Oct; 30(10):1221-9. PubMed ID: 8264112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
